<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[prasugrel Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/prasugrel.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to prasugrel]]></description>
	<s:counts start="0" returned="3" found="3" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Pharma Roundup: Lilly and Prasugrel, Roche and Genentech, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000780/pharma-roundup-lilly-and-prasugrel-roche-and-genentech-and-more/]]></link>
		<description><![CDATA[Prasugrel's FDA approval looks closer -- Prasugrel, the blood thinner on which Lilly is pinning so much hope, got a boost in a newly-published FDA document stating that "the Division recommends approval of prasugrel." The briefing is meant to sway the outside committee that will convene next week to advise...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 30 Jan 2009 16:40:38 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/prasugrel.html"><![CDATA[Prasugrel]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Moody's Cuts Lilly's Debt Rating; Daiichi Says It's Confident in Prasugrel]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000420/moodys-cuts-lillys-debt-rating-daiichi-says-its-confident-in-prasugrel/]]></link>
		<description><![CDATA[Moody's, the debt rating service, cut its rating of the quality of Eli Lilly's credit down to A1 from Aa3. The move indicates that Lilly's acquisition of ImClone has come with a price on top of the one on the sales tag. Moody's said:  Although the ImClone acquisition creates...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 23 Nov 2008 20:45:44 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/moody%2527s+corp..html"><![CDATA[Moody's Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/prasugrel.html"><![CDATA[Prasugrel]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCO</category>
		<category domain="tickers">MCO</category>
	</item>
	<item>
		<title><![CDATA[Prasugrel better on stent-related clots than Plavix: study]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200803/ai_n24969790]]></link>
		<description><![CDATA[CHICAGO, March 29, 2008 AFP &#8212; A cocktail of new anti-blood clot drug Prasugrel and aspirin reduces the risk of stent-related clots more than the standard treatment, according to a clinical trial review presented Saturday.  Prasugrel cut the risk of platelet formation around where a stent -- a small...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 29 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/aspirin.html"><![CDATA[aspirin]]></category>
		<category domain="http://resources.bnet.com/topic/chicago.html"><![CDATA[Chicago]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/prasugrel.html"><![CDATA[Prasugrel]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
